Laws & Regulations
Regulations Governing the Allocation and Purchase Limitation of Schedule 1 and 2 Controlled Drugs
1.Promulgated and Enforced by the Department of Health, Executive Yuan, Order No. 89008657 on 14 February 2000
2.Amended attached table by the Department of Health, Executive Yuan, Order No. 0929966003 on 14 January 2003
3.Amendment to Article 2, 4, 5 and 6, Promulgated by the Department of Health, Executive Yuan, Order No.0991800580 on 2 July 2010
4.Full text including 6 articles amended and promulgated on 8 November 2013 on Ministry of Health and Welfare order shushoushih no.1021850245
5.Amended attached table by the Ministry of Health and Welfare, Order No. 1031800418 on 30 June 2014
||The regulations are issued in accordance with Article 22 of the Controlled Drugs Act (hereinafter "this Act").
||For medical institutions, drug stores, veterinarian institutions and pasturage veterinarian institutions, the yearly (from January 1 to December 31 of the same year) purchases of schedule 1 and 2 controlled drugs quantities shall not exceed the requirement of the attached table. If the drug inventory exceeds half the annual quota, the purchase quantity shall be restricted.
The institutions in the preceding Paragraph, if the actual requirement exceeds the quota listed in the attached table, may submit controlled drugs quota increase application form and relevant data and apply to the Food and Drug Administration, Ministry of Health and Welfare (hereinafter "FDA"). After approval, the annual quota will follow the new approved quota.
||For research laboratories, the purchases of schedule 1 and 2 controlled drugs shall follow Article 6 of this Act approved medicine education and research experiment program required quantity restriction.
||For human medicine manufacturers and veterinary medicine manufacturers, the purchase of schedule 1 and 2 controlled drugs in the form of raw material drug to produce drugs containing controlled drug component, they shall fill out application form. The purchased quantities are limited by the production plan required raw material drug quantities. If the raw material drugs inventory exceeds 50% of the previous purchased quantity, the FDA may limit its purchase quantity.
If the above-mentioned applications for drugs in the form of raw material drugs are to produce schedule 3 and 4 controlled drugs, it shall follow Article 20 of this Act to apply for controlled drug production agreement form. If they are used to produce non-controlled drug, it shall be reported monthly, in accordance to the final retail sales objects' data of that drug, to the FDA and local health administration at each sales locality.
||The total quantities of schedule 1 and 2 controlled drugs for basic military medical units, shall be estimated annually (from January 1 to December 31 of the same year) by the military medical control organization. After the application to the FDA is approved, the purchases shall be in batches and made to the controlled drugs pharmaceutical plant of the FDA.
||The regulations shall come into force from the date of their promulgation.